Longevity doctor Peter Attia steps down from his CBS News contributor role after appearing in the Epstein files
Business Insider
February 23, 2026
AI-Generated Deep Dive Summary
Peter Attia, a prominent longevity influencer and doctor known for his work in extending lifespan, has stepped down from his new role as a CBS News contributor following the release of Jeffrey Epstein’s files. His name appears over 1,700 times in the documents, which include crude emails he exchanged with Epstein regarding women's genitalia. Attia acknowledged that these communications were "embarrassing, tasteless, and indefensible," adding that the person he is today would not have engaged in such behavior or associated with Epstein.
In addition to leaving CBS News, Attia has also resigned from his position as chief science officer at David Protein and is no longer listed as an advisor for Eight Sleep. These developments come after the Epstein files exposed numerous connections between the disgraced financier and other influential figures. For instance, Prince Andrew, Casey Wasserman (organizer of the 2028 Olympics), Kathryn Ruemmler (a top Goldman Sachs lawyer), and Brad Karp (chairman of Paul Weiss) have all faced professional consequences following their ties to Epstein.
The fallout highlights the lasting impact of past associations, particularly in high-profile industries like finance, media, and sports. As businesses and organizations grapple with reputational risks, individuals linked to controversial figures like Epstein are increasingly facing scrutiny and career setbacks. This case underscores the importance of ethical decision-making and the potential consequences of even distant connections to disgraced figures.
For readers interested in business, this story serves as a cautionary tale about the long-reaching effects of past actions and associations on professional credibility. It also raises questions about how organizations evaluate potential contributors or partners
Verticals
businessfinance
Originally published on Business Insider on 2/23/2026